4 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
Follow Suppuration: new trials by email Literature Review of Suppuration trials Research Report on Suppuration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gentian Violet Treatment for Hidradenitis Suppurativa Gentian Violet - Hidradenitis Suppurativa | Phase 2 | Withdrawn | Wake Forest University Health Sciences | 2025-08-01 | 2025-09-04 | |
| Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa Cannabis oil, Placebo - Hidradenitis Suppurativa | Phase 2 | Withdrawn | TO Pharmaceuticals | 2020-09-01 | 2021-08-04 | |
| The Use of Oral Steroids in the Treatment of Cellulitis Prednisone, Placebo Oral Tablet - Cellulitis, Erysipelas | Phase 2 | Withdrawn | Milton S. Hershey Medical Center | 2010-01-15 | 2017-07-25 | |
| Safety and Efficacy of NAFT900 in Children With Tinea Capitis Naftifine hydrochloride foam, 3%, Vehicle - Tinea Capitis | Phase 2 | Withdrawn | Merz North America, Inc. | 2016-09-09 |
Cellulitis (2) · Hidradenitis Suppurativa (2) · Erysipelas (1) · Marijuana Abuse (1) · Tinea Capitis (1)
Bacterial Infections and Mycoses (4) · Infections (4) · Skin Diseases (4) · Skin Diseases, Infectious (4) · Skin and Connective Tissue Diseases (4) · Bacterial Infections (3) · Skin Diseases, Bacterial (3) · Connective Tissue Diseases (2) · Hidradenitis (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Sweat Gland Diseases (2) · Chemically-Induced Disorders (1)
Gentian Violet (1) · Olive Oil (1) · Prednisone (1) · nabiximols (1)
Merz North America, Inc. (1) · Milton S. Hershey Medical Center (1) · TO Pharmaceuticals (1) · Wake Forest University Health Sciences (1)
Israel (1) · United States (1)
Michael Kuligowski, MD (1) · Rita Pichardo-Geisinger, MD (1) · Scott Goldstein, DO (1)